Thread by @tanyawildes

Blown away by rising star @mwschoen's masterful storytelling of how he is trying to understand and eradicate racial disparities in myeloma treatment and outcomes...
file:///var/folders/mw/0w9f93f97wscrp764dmz0k900000gp/T/com.apple.iChat/Messages/Transfers/IMG_6462.jpeg #ASH19

@mwschoen Dr. Schoen walks us through a hypothesis that renal impairment and racial differences in estimating renal function may impact treatment and outcome: 1) Pts with renal dies less likely to receive lenalidomide.

@mwschoen 2) Black veterans have higher creatinine but better GFR... if clinician only looks at creatinine, may err in understanding pts renal function.

@mwschoen 3) Black patients more likely to be coded as having renal disease by ICD9 codes

@mwschoen 4) Black pts less likely to receive lenalidomide

@mwschoen 5) Summary - results lead to hypothesis that higher rates of diagnosis of renal disease based on erroneous interpretation of Creatinine in black patients may mediate racial disparities in treatment